Repetitive transcranial magnetic stimulation (rTMS) for anxiety disorders - A possible therapeutic option?: A systematic review;Repetitive transkranielle Magnetstimulation (rTMS) bei Angsterkrankungen - eine mögliche Therapieoption?: Eine systematische Übersicht

Fortschritte der Neurologie Psychiatrie

Volumn 81, Issue 10, 2013, Pages 550-560

  Vennewald, N ^a   Diemer, J ^b   Zwanzger, P ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

anxiety disorders; panic disorder; PTSD; repetitive transcranial magnetic stimulation; rTMS

Indexed keywords

ANXIETY DISORDER; ARTICLE; HUMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPEAT PROCEDURE; SYSTEMATIC REVIEW; THERAPY EFFECT; TRANSCRANIAL MAGNETIC STIMULATION;

AGORAPHOBIA; ANXIETY DISORDERS; CLINICAL TRIALS AS TOPIC; HUMANS; PANIC DISORDER; PHOBIC DISORDERS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STRESS DISORDERS, POST-TRAUMATIC; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

EID: 84885149989     PISSN: 07204299     EISSN: 14393522     Source Type: Journal    
DOI: 10.1055/s-0033-1335979     Document Type: Article

References (98)

1. Greenberg P. E., Sisitsky T., Kessler R. C. et al. The economic burden of anxiety disorders in the 1990s. J Clin Psychiatry: 1999; 60 07 427 435 (Pubitemid 29369796)
2. Kessler R. C., Berglund P., Demler O. et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry: 2005; 62 593 602 (Pubitemid 40973434)
3. Pallanti S., Bernardi S. Neurobiology of repeated Transcranial Magnetic Stimulation in the treatment of anxiety: a critical review. Int Clin Psychopharmacol: 2009; 24 163 173
4. Mendlowicz M. V., Stein M. B. Quality of life in individuals with anxiety disorders. Am J Psychiatry: 2000; 157 669 682 (Pubitemid 30249642)
5. Stein M. B., Roy-Byrne P. P., Craske M. G. et al. Functional impact and health utility of anxiety disorders in primary care outpatients. Med Care: 2005; 43 1164 1170 (Pubitemid 43012172)
6. Kessler R. C., McGonagle K. A., Zhao S. et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry: 1994; 51 01 8 19 (Pubitemid 24028993)
7. Byers A. L., Yaffe K., Covinsky K. E. et al. High occurrence of mood and anxiety disorders among older adults: the National Comorbidity Survey replication. Arch Gen Psychiatry: 2010; 67 05 489 496
8. Gustavsson A., Svensson M., Jacobi F. et al. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol: 2011; 21 10 718 779
9. Dengler W., Selbmann H. K. (Hrsg.). Praxisleitlinien in Psychiatrie und Psychotherapie. Bd. 2 Leitlinien zur Diagnostik und Therapie von Angsterkrankungen. 1. Aufl Darmstadt Steinkopff: 2001
10. Bandelow B., Zohar J., Hollander E. et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision. World J Biol Psychiatry: 2008; 9 04 248 312
11. Hofmann S. G., Smits J. A. Cognitive-behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trials. J Clin Psychiatry: 2008; 69 04 621 632 (Pubitemid 351792338)
12. James A., Soler A., Weatherall R. Cognitive behavioural therapy for anxiety disorders in children and adolescents. Cochrane Database Syst Rev: 2005; 4 CD004690
13. Bundespsychotherapeutenkammer BPtK-Studie zu Wartezeiten in der ambulanten psychotherapeutischen Versorgung: Umfrage der Landespsychotherapeutenkammern und der BPtK. Berlin: 2011
14. Taylor S., Abramowitz J. S., McKay D. Non-adherence and non-response in the treatment of anxiety disorders. J Anxiety Disord: 2012; 26 05 583 589
15. Bandelow B., Rüther E. Treatment-resistant panic disorder. CNS Spectr: 2004; 9 10 725 739
16. Heilman K. M., Gilmore R. L. Cortical influences in emotion. J Clin Neurophysiol: 2008; 15 05 409 423
17. Davis M. The role of the amygdala in fear and anxiety. Annu Rev Neurosci: 1992; 15 353 375
18. Davis M., Walker D. L., Miles L. et al. Phasic vs sustained fear in rats and humans: Role of the extended amygdala in fear vs anxiety. Neuropsychopharmacol: 2010; 35 105 135
19. Davis M. The role of the amygdala in conditioned and unconditioned fear and anxiety. In: Aggleton J. P. (ed.) The Amygdala: a functional analysis. Oxford Oxford University: 2000; 213 253
20. Charney D. S. Neuroanatomical circuits modulating fear and anxiety behaviours. Acta Psychiatr Scand: 2003; 417 38 50
21. Etkin A., Wager T. D. Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am J Psychiatry: 2007; 164 1476 1488 (Pubitemid 350069724)
22. Hariri A. R., Mattay V. S., Tessitore A. et al. Neocortical modulation of the amygdala response to fearful stimuli. Biol Psychiatry: 2003; 53 494 501 (Pubitemid 36331888)
23. Hariri A. R., Bookheimer S. Y., Mazziotta J. C. Modulating emotional responses: effects of a neocortical network on the limbic system. NeuroReport: 2000; 11 43 48 (Pubitemid 30053387)
24. Taylor S. F., Phan K. L., Decker L. R. et al. Subjective rating of emotionally salient stimuli modulates neural activity. NeuroImage: 2003; 18 650 659 (Pubitemid 36349415)
25. Dresler T., Ehlis A. C., Plichta M. M. et al. Panic disorder and a possible treatment approach by means of high-frequency rTMS: a case report. World J Biol Psychiatry: 2009; 10 991 997
26. Domschke K., Braun M., Ohrmann P. et al. Association of the functional 1019C/G 5-HT1A polymorphism with prefrontal cortex and amygdala activation measured with 3 T fMRI in panic disorder. Int J Neuropsychopharmacol: 2006; 9 349 355 (Pubitemid 43780503)
27. Boshuisen M. L., Ter H. GJ, Paans A. MJ et al. rCBF differences between panic disorder patients and control subjects during anticipatory anxiety and rest. Biol Psychiatry: 2002; 52 126 135 (Pubitemid 34756558)
28. DeRubeis R. J., Siegle G. J., Hollon S. D. Cognitive therapy versus medication for depression: treatment outcomes and neural mechanisms. Nat Rev Neurosci: 2008; 9 788 796
29. Reuter-Lorenz P. A., Davidson R. J. Differential contributions of the two cerebral hemispheres to the perception of happy and sad faces. Neuropsychologia: 1981; 19 609 613 (Pubitemid 11060641)
30. Wedding D., Stalans L. Hemispheric differences in the perception of positive and negative faces. Int J Neuroscience: 1985; 27 277 281
31. Schutter D. J., de Weijer A. D., Meuwese J. D. et al. Interrelations between motivational stance, cortical excitability, and the frontal electroencephalogram asymmetry of emotion: a transcranial magnetic stimulation study. Hum Brain Mapp: 2008; 29 05 574 580 (Pubitemid 351706805)
32. Balconi M., Mazza G. Lateralisation effect in comprehension of emotional facial expression: a comparison between EEG alpha band power and behavioural inhibition (BIS) and activation (BAS) systems. Laterality: 2010; 15 03 361 384
33. Wiedemann G., Pauli P., Dengler W. et al. Frontal brain asymmetry as a biological substrate of emotions in patients with panic disorders. Arch Gen Psychiatry: 1999; 56 78 84 (Pubitemid 29055053)
34. Rauch S. L., Savage C. R., Alpert N. M. et al. The functional neuroanatomy of anxiety: a study of three disorders using positron emission tomography and symptom provocation. Biol Psychiatry: 1997; 42 06 446 452 (Pubitemid 27394613)
35. Lang N., Siebner H. R. Repetitive Transkranielle Magnetstimulation. In: Siebner H. R., Ziemann U., (Hrsg.) Das TMS-Handbuch - Handbuch der Transkraniellen Magnetstimulation. 1. Aufl Heidelberg Springer: 2007; 500 509
36. Siebner H. R., Ziemann U. Hirnstimulation - Physiologische Grundlagen. In: Siebner H. R., Ziemann U., (Hrsg.) Das TMS-Handbuch - Handbuch der Transkraniellen Magnetstimulation. 1. Aufl Heidelberg Springer: 2007; 28 44
37. Kanno M., Matsumoto M., Togashi H. et al. Effects of repetitive Transcranial Magnetic Stimulation on behavioral and neurochemical changes in rats during an elevated plus-maze test. J Neurol Sci: 2003; 211 5 14 (Pubitemid 36593261)
38. Keck M. E., Engelmann M., Müller M. B. et al. Repetitive Transcranial Magnetic Stimulation induces active coping strategies and attenuates the neuroendocrine stress response in rats. J Psychiatr Res: 2000; 34 04 265 276
39. Keck M. E., Welt T., Post A. et al. Neuroendocrine and behavioral effects of repetitive Transcranial Magnetic Stimulation in a psychopathological animal model are suggestive of antidepressant-like effects. Neuropsychopharmacol: 2001; 24 337 349 (Pubitemid 32157550)
40. Hedges D. W., Higginbotham B. J., Salyer D. L. et al. Transcranial Magnetic Stimulation effects on one-trial learning and response to anxiogenic stimuli in adult male rats. J ECT: 2005; 21 01 25 30 (Pubitemid 40471322)
41. Lisanby S. H., Belmaker R. H. Animal models of the mechanisms of action of repetitive Transcranial Magnetic Stimulation (rTMS): comparisons with electroconvulsive shock (ECS). Depress Anxiety: 2000; 12 03 178 187
42. Keck M. E., Welt T., Müller M. B. et al. Repetitive Transcranial Magnetic stimulation increases the release of dopamine in the mesolimbic and mesostriatal system. Neuropharmacol: 2002; 43 01 101 109 (Pubitemid 35245679)
43. Huang Y. Z., Edwards M. J., Rounis E. et al. Theta Burst Stimulation of the human motor cortex. Neuron: 2005; 45 02 201 206 (Pubitemid 40128115)
44. Cárdenas-Morales L., Grön G., Kammer T. et al. Exploring the after-effects of Theta Burst Magnetic Stimulation on the human motor cortex: a functional imaging study. Hum Brain Mapp: 2011; 32 11 1948 1960
45. van Honk J., Schutter D. J., d'Alfonso A. A. et al. 1 hz rTMS over the right prefrontal cortex reduces vigilant attention to unmasked but not to masked fearful faces. Biol Psychiatry: 2002; 52 04 312 317 (Pubitemid 35245970)
46. Baeken C., De Raedt R., Van Schuerbeek P. et al. Right prefrontal HF-rTMS attenuates right amygdala processing of negatively valenced emotional stimuli in healthy females. Behav Brain Res: 2010; 214 02 450 455
47. Rumi D. O., Gattaz W. F., Rigonatti S. P. et al. Transcranial Magnetic Stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study. Biol Psychiatry: 2005; 57 02 162 166 (Pubitemid 40094716)
48. Herwig U., Fallgatter A. J., Höppner J. et al. Antidepressant effects of augmentative Transcranial Magnetic Stimulation: randomised multicentre trial. Br J Psychiatry: 2007; 191 441 448 (Pubitemid 350069586)
49. Jaafari N., Rachid F., Rotge J. Y. et al. Safety and efficacy of repetitive Transcranial Magnetic Stimulation in the treatment of obsessive-compulsive disorder: a review. World J Biol Psychiatry: 2012; 13 03 164 177
50. Speer A. M., Kimbrell T. A., Wassermann E. M. et al. Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients. Biol Psychiatry: 2000; 48 12 1133 1141 (Pubitemid 32008437)
51. Michael N., Gösling M., Reutemann M. et al. Metabolic changes after repetitive Transcranial Magnetic Stimulation (rTMS) of the left prefrontal cortex: a sham-controlled proton magnetic resonance spectroscopy (1H MRS) study of healthy brain. Eur J Neurosci: 2003; 17 11 2462 2468 (Pubitemid 36793755)
52. George M. S., Wassermann E. M., Post R. M. Transcranial Magnetic Stimulation: a neuropsychiatric tool for the 21st century. J Neuropsychiatry Clin Neurosci: 1996; 8 04 373 382 (Pubitemid 26381958)
53. O'Reardon J. P., Solvason H. B., Janicak P. G. et al. Efficacy and safety of Transcranial Magnetic Stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry: 2007; 62 11 1208 1216 (Pubitemid 350060890)
54. Schlaepfer T. E., Kosel M., Nemeroff C. B. Efficacy of repetitive Transcranial Magnetic Stimulation (rTMS) in the treatment of affective disorders. Neuropsychopharmacology: 2003; 28 02 201 205
55. Padberg F., Zwanzger P., Thoma H. et al. Repetitive Transcranial Magnetic Stimulation (rTMS) in pharmacotherapy-refractory major depression: comparative study of fast, slow and sham rTMS. Psychiatry Res: 1999; 88 03 163 171 (Pubitemid 30074173)
56. Pascual-Leone A., Rubio B., Pallardó F. et al. Rapid-rate Transcranial Magnetic Stimulation of left dorsolateral prefrontal cortex in drug-resistant depression. Lancet: 1996; 348 9022 233 237 (Pubitemid 26254198)
57. Koenigs M., Grafman J. The functional neuroanatomy of depression: distinct roles for ventromedial and dorsolateral prefrontal cortex. Behav Brain Res: 2009; 201 239 243
58. Daskalakis Z. J., Levinson A. J., Fitzgerald P. B. Repetitive Transcranial Magnetic Stimulation for major depressive disorder: a review. Can J Psychiatry: 2008; 53 09 555 566
59. Grossheinrich N., Rau A., Pogarell O. et al. Theta Burst Stimulation of the prefrontal cortex: safety and impact on cognition, mood, and resting electroencephalogram. Biol Psychiatry: 2009; 65 09 778 784
60. Rossi S., Hallett M., Rossini P. M. et al. Safety, ethical considerations, and application guidelines for the use of Transcranial Magnetic Stimulation in clinical practice and research. Clin Neurophysiol: 2009; 120 12 2008 2039
61. Machii K., Cohen D., Ramos-Estebanez C. et al. Safety of rTMS to non-motor cortical areas in healthy participants and patients. Clin Neurophysiol: 2006; 117 02 455 471 (Pubitemid 43228037)
62. Zwanzger P., Fallgatter A. J., Zavorotnyy M. et al. Anxiolytic effects of Transcranial Magnetic Stimulation - an alternative treatment option in anxiety disorders? J Neural Transm: 2009; 116 06 767 775
63. Diemer J., Vennewald N., Domschke K. et al. Therapy-refractory panic: current research areas as possible perspectives in the treatment of anxiety. Eur Arch Psychiatry Clin Neurosci: 2010; 260 02 S127 S131
64. Phillips K. A., Stein D. J., Rauch S. L. et al. Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V? Depress Anxiety: 2010; 27 06 528 555
65. Hollander E., Braun A., Simeon D. Should OCD leave the anxiety disorders in DSM-V? The case for obsessive compulsive-related disorders. Depress Anxiety: 2008; 25 04 317 329 (Pubitemid 351614566)
66. Berkowitz R. L., Coplan J. D., Reddy D. P. et al. The human dimension: how the prefrontal cortex modulates the subcortical fear response. Rev Neurosci: 2007; 18 03 191 207
67. Sleith C. The Scottish Intercollegiate Guidelines Network (SIGN): Methodology Checklist 2: Controlled Trial. Zugriff am 18.03.2013 von http://www.sign.ac.uk/methodology/checklists.html
68. Guaiana G., Mortimer A. M., Robertson C. Efficacy of Transcranial Magnetic Stimulation in panic disorder: a case report. Aust N Z J Psychiatry: 2005; 39 11 1047 (Pubitemid 43904446)
69. Zwanzger P., Minov C., Ella R. et al. Transcranial Magnetic Stimulation for panic. Am J Psychiatry: 2002; 159 02 315 316
70. Mantovani A., Lisanby S. H., Pieraccini F. et al. Repetitive Transcranial Magnetic Stimulation (rTMS) in the treatment of panic disorder (PD) with comorbid major depression. J Affect Disord: 2007; 102 01 277 280 (Pubitemid 47042168)
71. Prasko J., Záleský R., Bares M. et al. The effect of repetitive Transcranial Magnetic Stimulation (rTMS) add on serotonin reuptake inhibitors in patients with panic disorder: a randomized, double blind sham controlled study. Neuro Endocrinol Lett: 2007; 28 01 33 38 (Pubitemid 46291144)
72. Mantovani A., Aly M., Dagan Y. et al. Randomized sham controlled Transcranial Magnetic Stimulation to the dorsolateral prefrontal cortex for the treatment of panic disorder with comorbid depression. J Affect Disorders: 2013; 144 01 153 159
73. Bystritsky A., Kaplan J. T., Feusner J. D. et al. A preliminary study of fMRI-guided rTMS in the treatment of generalized anxiety disorder. J Clin Psychiatry: 2008; 69 07 1092 1098 (Pubitemid 352031592)
74. Bystritsky A., Kerwin L. E., Feusner J. D. A preliminary study of fMRI-guided rTMS in the treatment of generalized anxiety disorder: 6-month follow up. J Clin Psychiatry: 2009; 70 03 431 432
75. De Bellis M. D., Casey B. J., Dahl R. E. et al. A pilot study of amygdala volumes in pediatric generalized anxiety disorder. Biol Psychiatry: 2000; 48 01 51 57 (Pubitemid 30407149)
76. Etkin A., Prater K. E., Schatzberg A. F. et al. Disrupted amygdalar subregion functional connectivity and evidence of a compensatory network in generalized anxiety disorder. Arch Gen Psychiatry: 2009; 66 12 1361 1372
77. Schienle A., Ebner F., Schäfer A. Localized gray matter volume abnormalities in generalized anxiety disorder. Eur Arch Psychiatry Clin Neurosci: 2011; 261 04 303 307
78. Monk C. S., Telzer E. H., Mogg K. et al. Amygdala and ventrolateral prefrontal cortex activation to masked angry faces in children and adolescents with generalized anxiety disorder. Arch Gen Psychiatry: 2008; 65 05 568 576 (Pubitemid 351645052)
79. McCann U. D., Kimbrell T. A., Morgan C. M. et al. Repetitive Transcranial Magnetic Stimulation for posttraumatic stress disorder. Arch Gen Psychiatry: 1998; 55 03 276 279
80. Grisaru N., Amir M., Cohen H. et al. Effect of Transcranial Magnetic Stimulation in posttraumatic stress disorder: a preliminary study. Biol Psychiatry: 1998; 44 01 52 55 (Pubitemid 28305541)
81. Rosenberg P. B., Mehndiratta R. B., Mehndiratta Y. P. et al. Repetitive Transcranial Magnetic Stimulation treatment of comorbid posttraumatic stress disorder and major depression. J Neuropsychiatry Clin Neurosci: 2002; 14 03 270 276 (Pubitemid 34827681)
82. Cohen H., Kaplan Z., Kotler M. et al. Repetitive Transcranial Magnetic Stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry: 2004; 161 03 515 524 (Pubitemid 38326107)
83. Osuch E. A., Benson B. E., Luckenbaugh D. A. et al. Repetitive TMS combined with exposure therapy for PTSD: a preliminary study. J Anxiety Disord: 2009; 23 01 54 59
84. Boggio P. S., Rocha M., Oliveira M. O. et al. Noninvasive brain stimulation with high-frequency and low-intensity repetitive Transcranial Magnetic Stimulation treatment for posttraumatic stress disorder. J Clin Psychiatry: 2010; 71 08 992 999
85. Watts B. V., Landon B., Groft A. et al. A sham controlled study of repetitive Transcranial Magnetic Stimulation for posttraumatic stress disorder. Brain Stimul: 2012; 5 01 38 43
86. Couturier J. F. Efficacy of rapid-rate repetitive Transcranial Magnetic Stimulation in the treatment of depression: a systematic review and meta-analysis. J Psychiatry Neurosci: 2005; 30 02 83 90
87. Galletly C., Gill S., Clarke P. et al. A randomized trial comparing repetitive Transcranial Magnetic Stimulation given 3 days/week and 5 days/week for the treatment of major depression: is efficacy related to the duration of treatment or the number of treatments? Psychol Med: 2012; 42 05 981 988
88. Padberg F., Zwanzger P., Keck M. et al. Repetitive Transcranial Magnetic Stimulation (rTMS) in major depression: relation between efficacy and stimulation intensity. Neuropsychopharmacol: 2002; 27 04 638 645
89. Cheeran B., Talelli P., Mori F. et al. A common polymorphism in the brain-derived neurotrophic factor gene (BDNF) modulates human cortical plasticity and the response to rTMS. J Physiol: 2008; 586 5717 5725
90. Pell G. S., Roth Y., Zangen A. Modulation of cortical excitability induced by repetitive transcranial magnetic stimulation: influence of timing and geometrical parameters and underlying mechanisms. Prog Neurobiol: 2011; 93 01 59 98
91. Siebner H. R., Hartwigsen G., Kassuba T. et al. How does Transcranial Magnetic Stimulation modify neuronal activity in the brain? Implications for studies of cognition. Cortex: 2009; 45 09 1035 1042
92. Roth Y., Amir A., Levkovitz Y. et al. Three-dimensional distribution of the electric field induced in the brain by Transcranial Magnetic Stimulation using figure-8 and deep H-coils. J Clin Neurophysiol: 2007; 24 01 31 38 (Pubitemid 46207941)
93. Zangen A., Roth Y., Voller B. et al. Transcranial Magnetic Stimulation of deep brain regions: evidence for efficacy of the H-coil. Clin Neurophysiol: 2005; 116 04 775 779 (Pubitemid 40431994)
94. Levkovitz Y., Roth Y., Harel E. V. et al. A randomized controlled feasibility and safety study of deep Transcranial Magnetic Stimulation. Clin Neurophysiol: 2007; 118 12 2730 2744 (Pubitemid 350180620)
95. Harel E. V., Rabany L., Deutsch L. et al. H-coil repetitive Transcranial Magnetic Stimulation for treatment resistant major depressive disorder: An 18-week continuation safety and feasibility study. World J Biol Psychiatry [Epub ahead of print]
96. Levkovitz Y., Sheer A., Harel E. V. et al. Differential effects of deep TMS of the prefrontal cortex on apathy and depression. Brain Stimul: 2011; 4 04 266 274
97. Lisanby S. H., Gutman D., Luber B. et al. Sham TMS: intracerebral measurement of the induced electrical field and the induction of motor-evoked potentials. Biol Psychiatry: 2001; 49 05 460 463 (Pubitemid 32234309)
98. Rossi S., Ferro M., Cincotta M. et al. A real electro-magnetic placebo (REMP) device for sham Transcranial Magnetic Stimulation (TMS). Clin Neurophysiol: 2007; 118 03 709 716 (Pubitemid 46205423)